Richard Aplenc, MD, PhD, MSCE
Dr. Aplenc's primary focus is on the treatment of pediatric acute myelogenous leukemia (AML). One of Dr. Aplenc's first patients had acute myeloid leukemia (AML). His experience caring for her changed the path of his career.
Areas of Expertise:
Acute myeloid leukemia, Novel therapies
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)